Neogenomics, Inc.
NEO
$6.45
-$0.155-2.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -141.88% | 4.21% | -6.97% | 4.41% | 23.38% |
| Total Depreciation and Amortization | -4.66% | -2.95% | -0.94% | -0.82% | -0.83% |
| Total Amortization of Deferred Charges | -31.50% | 1.38% | 1.39% | 1.25% | 1.25% |
| Total Other Non-Cash Items | 189.14% | 20.58% | 9.45% | 8.68% | 32.30% |
| Change in Net Operating Assets | 579.25% | -7.59% | -211.81% | 84.01% | 141.35% |
| Cash from Operations | 46.34% | 2.27% | -44.89% | 268.20% | 997.42% |
| Capital Expenditure | 51.65% | 19.43% | -64.36% | -152.67% | -74.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -85.29% | -59.92% | -74.72% | -70.98% | -9.14% |
| Cash from Investing | -227.36% | -75.49% | -131.79% | -116.89% | -51.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 16.30% | 6.68% | -36.24% | -- |
| Repurchase of Common Stock | -16.30% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -108.41% | -- | -39.52% | -- | -- |
| Cash from Financing | -10,396.69% | 16.30% | -45.91% | -36.07% | 2,971.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -926.34% | -96.88% | -86.15% | -59.76% | 72.08% |